Search results
Learn More. Recordati is a global pharmaceutical company, listed on the Italian stock exchange, with over 4,450 employees. We develop and commercialise medicines to serve people living with common diseases, as well as those living with some of the rarest, in around 150 countries.
Today, almost 100 years and three generations later, Giovanni’s focus and determination lives on. His company, Recordati, is now a global pharmaceutical group, listed on the Italian stock exchange, with over 4,450 employees.
At Recordati Rare Diseases, we focus on the few - those affected by rare diseases. We believe that every single patient has the right to the best possible treatment. Patients with rare diseases are our top priority. They are at the core of our planning, our thinking and our actions.
May 16, 2024 · Latest and previous presentations and reports including company presentations and financial results, annual & interim reports and archived material.
Recordati has a strong and proven heritage of supporting people living with a wide range of common illnesses that affect large populations day-to-day – creating value for patients, payers and physicians across primary and specialty care with both prescription and self-medication treatments.
May 11, 2023 · Italian drug maker Recordati hiked its 2023 guidance on Thursday, as it posted first-quarter results showing solid growth for its specialty and primary care segments.
Recordati Rare Diseases develops high-impact therapies for devastating rare diseases. At Recordati, we focus on the few - those affected by rare diseases. They are our top priority and at the core of everything we do.
Recordati is dedicated to partnering, discovering and developing innovative, value added medication that improve the quality of life and help people to enjoy longer, healthier and a more productive life. Since 2007 for Rare diseases & 2018 for Specialty and Primary care.
An international pharmaceutical group. RECORDATI, established in 1926, is an international pharmaceutical group, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations worldwide, including in the BeNeLUX.
With its beginnings in a family run pharmacy in Correggio, Italy in the 1920s, Recordati is now a global pharmaceutical force, listed on the Italian stock exchange, with over 4,300 employees.
